MEDICAMEN BIOTECH
Back to Cashflow Statement
|
MEDICAMEN BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.47 Cr | ₹6.31 Cr | ₹29 Cr | ₹4.30 Cr | ₹5.84 Cr |
What is the latest Cash Flow from Financing Activities ratio of MEDICAMEN BIOTECH ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1.47 Cr |
| Mar2024 | ₹6.31 Cr |
| Mar2023 | ₹29 Cr |
| Mar2022 | ₹4.30 Cr |
| Mar2021 | ₹5.84 Cr |
How is Cash Flow from Financing Activities of MEDICAMEN BIOTECH Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.47 Cr | Negative | |
| Mar2024 | ₹6.31 Cr | -78.32 | |
| Mar2023 | ₹29 Cr | 577.69 | |
| Mar2022 | ₹4.30 Cr | -26.39 | |
| Mar2021 | ₹5.84 Cr | - | |
Compare Cash Flow from Financing Activities of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹485.2 Cr | -7.8% | -13.2% | -28.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,590.0 Cr | -2% | -6.1% | -6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,577.0 Cr | -0.8% | -0.8% | 8.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,301.0 Cr | 0% | 2.7% | 11% | Stock Analytics | |
| CIPLA | ₹120,471.0 Cr | -0.6% | -2.6% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,660.0 Cr | -1.3% | 0.6% | -6.4% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | -7.8% |
-13.2% |
-28.3% |
| SENSEX | -1% |
-1.2% |
7.9% |
You may also like the below Video Courses